Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Hong Klinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.2% 7.0% 8.0% 7.8% 8.1% 7.4% 7.3% 7.0%   Credit score (0-100)   44 36 31 30 29 32 33 34   Credit rating   BBB BBB BB BB BB BB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,663 1,550 996 1,169 1,189 1,143 0.0 0.0   EBITDA   228 238 -172 225 217 -64.7 0.0 0.0   EBIT   65.7 22.2 -343 55.3 35.5 -248 0.0 0.0   Pre-tax profit (PTP)   59.5 11.6 -356.1 41.1 8.8 -272.0 0.0 0.0   Net earnings   46.1 16.7 -281.8 30.1 6.8 -234.6 0.0 0.0   Pre-tax profit without non-rec. items   59.5 11.6 -356 41.1 8.8 -272 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 37.6 28.2 18.8 9.4 0.0 0.0 0.0   Shareholders equity total   3,284 1,801 1,519 1,549 1,556 1,321 1,271 1,271   Interest-bearing liabilities   239 323 696 899 973 1,300 174 174   Balance sheet total (assets)   4,237 2,730 2,864 3,062 3,111 3,156 1,445 1,445   Net Debt   -1,693 173 274 -147 -316 -253 174 174     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,663 1,550 996 1,169 1,189 1,143 0.0 0.0   Gross profit growth   0.0% -6.8% -35.8% 17.4% 1.7% -3.9% -100.0% 0.0%   Employees   3 3 3 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,237 2,730 2,864 3,062 3,111 3,156 1,445 1,445   Balance sheet change%   0.0% -35.6% 4.9% 6.9% 1.6% 1.5% -54.2% 0.0%   Added value   227.7 238.2 -171.7 225.5 205.7 -64.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   2,086 -339 -342 -340 -352 -353 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.0% 1.4% -34.5% 4.7% 3.0% -21.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.6% 0.6% -12.3% 1.9% 1.2% -7.9% 0.0% 0.0%   ROI %   1.6% 0.7% -13.1% 2.0% 1.2% -8.5% 0.0% 0.0%   ROE %   1.4% 0.7% -17.0% 2.0% 0.4% -16.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   77.5% 66.0% 53.0% 50.6% 50.0% 41.9% 88.0% 88.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -743.3% 72.5% -159.4% -65.3% -145.2% 391.4% 0.0% 0.0%   Gearing %   7.3% 17.9% 45.8% 58.1% 62.5% 98.4% 13.7% 13.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.2% 3.8% 2.5% 1.8% 2.8% 2.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.2 0.3 0.6 0.9 1.1 1.0 0.0 0.0   Current Ratio   4.3 1.3 1.0 1.1 1.2 1.1 0.0 0.0   Cash and cash equivalent   1,932.2 150.1 422.5 1,046.5 1,288.8 1,553.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,530.6 135.5 -11.8 156.7 296.1 194.0 -87.0 -87.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   76 79 -57 75 69 -22 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   76 79 -57 75 72 -22 0 0   EBIT / employee   22 7 -114 18 12 -83 0 0   Net earnings / employee   15 6 -94 10 2 -78 0 0